In vivo measurement of fluxes through metabolic pathways: the missing link in functional genomics and pharmaceutical research.

In the postgenomic era of biology, much attention has been given to functional genomics, or the relation between genes and higher levels of organization in the cell. The latter are typically represented as mRNA, protein, or organic metabolite complements. The theme of this review is that the operational unit of function in complex biological systems is more properly seen as the fully assembled metabolic pathway in the whole organism. Due to the connectivity, interactions, and complexity of metabolic pathways, the measurement of components is an inadequate method for predicting phenotype. Measurement of the outputs of pathways (molecular fluxes) involves different tools than static measures of components, however. Here, we review recently developed stable isotope-mass spectrometric tools for measuring fluxes through metabolic pathways in vivo, focusing on the response to dietary macronutrients (carbohydrates and fats). Methods discussed include measurement of lipid dynamics, DNA replication, hepatic assembly of lipoproteins, and long-lived protein synthesis. Measuring fluxes through multiple pathways concurrently allows regulatory themes to emerge. Use of 2H2O-labeling is emerging as a particularly powerful approach for multiple concurrent biosynthetic flux measurements. Several examples demonstrate that pathway flux results are often unexpected and not predicted by classic biochemistry or the expression of genes and proteins.

[1]  J. Bailey,et al.  Toward a science of metabolic engineering , 1991, Science.

[2]  G F Cahill,et al.  Starvation in man. , 1970, The New England journal of medicine.

[3]  M. Hellerstein,et al.  Measurement of de novo hepatic lipogenesis in humans using stable isotopes. , 1991, The Journal of clinical investigation.

[4]  R. Krauss,et al.  Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. , 1999, The Journal of clinical investigation.

[5]  David A. Fell,et al.  Increasing the flux in metabolic pathways: A metabolic control analysis perspective , 1998, Biotechnology and bioengineering.

[6]  A. Goodridge,et al.  Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis. , 1995, Physiological reviews.

[7]  M. Hellerstein,et al.  Measurement of mitochondrial DNA synthesis in vivo using a stable isotope-mass spectrometric technique. , 2003, Journal of applied physiology.

[8]  N. Tygstrup,et al.  Ethanol metabolism and production of free acetate in the human liver. , 1962, The Journal of clinical investigation.

[9]  J. McCune,et al.  Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Parks,et al.  Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. , 2000, The American journal of clinical nutrition.

[11]  D. A. Clayton,et al.  Replication and transcription of vertebrate mitochondrial DNA. , 1991, Annual review of cell biology.

[12]  C. Linder The influence of genetic background on spontaneous and genetically engineered mouse models of complex diseases. , 2001, Lab animal.

[13]  C. Lieber,et al.  The effect of ethanol on fatty acid metabolism; stimulation of hepatic fatty acid synthesis in vitro. , 1961, The Journal of clinical investigation.

[14]  B. Yandell,et al.  The expression of adipogenic genes is decreased in obesity and diabetes mellitus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Houseknecht,et al.  The biology of leptin: a review. , 1998, Journal of animal science.

[16]  E. Jéquier,et al.  The effect of ethanol on fat storage in healthy subjects. , 1992, The New England journal of medicine.

[17]  J. Hill,et al.  Reduced insulin suppression of glucose appearance is related to susceptibility to dietary obesity in rats. , 1997, The American journal of physiology.

[18]  M. Hellerstein,et al.  Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers. , 1992, The American journal of physiology.

[19]  H. Sul,et al.  Regulation of fat synthesis and adipose differentiation. , 1998, Progress in nucleic acid research and molecular biology.

[20]  E. Khairallah,et al.  Assessment of protein turnover in perfused rat liver. Evidence for amino acid compartmentation from differential labeling of free and tRNA-gound valine. , 1976, The Journal of biological chemistry.

[21]  J. Moss,et al.  Acetyl coenzyme A carboxylase. , 1974, Current topics in cellular regulation.

[22]  M. Hellerstein,et al.  Measurement of T-cell kinetics: recent methodologic advances. , 1999, Immunology today.

[23]  D. J. Millward,et al.  Protein turnover in mammalian tissues and in the whole body , 1978 .

[24]  Steven G. Deeks,et al.  Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans , 1999, Nature Medicine.

[25]  J. Hokanson,et al.  Hypertriglyceridemia as a cardiovascular risk factor. , 1998, The American journal of cardiology.

[26]  S. Turner,et al.  Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. , 1995, The Journal of clinical investigation.

[27]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[28]  C. Newgard,et al.  Reversing adipocyte differentiation: implications for treatment of obesity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Hellerstein,et al.  Regulation of hepatic de novo lipogenesis in humans. , 1996, Annual review of nutrition.

[30]  R. Arky,et al.  Acute antilipolytic effects of ethyl alcohol and acetate in man. , 1968, The Journal of laboratory and clinical medicine.

[31]  M. Hellerstein,et al.  Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations. , 1999, The American journal of physiology.

[32]  G. Brooks,et al.  Biochemical adaptation of mitochondria, muscle, and whole-animal respiration to endurance training. , 1981, Archives of biochemistry and biophysics.

[33]  E. Leiter Mice with targeted gene disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions , 2002, Diabetologia.

[34]  M. Hellerstein,et al.  Gluconeogenesis and Intrahepatic Triose Phosphate Flux in Response to Fasting or Substrate Loads. APPLICATION OF THE MASS ISOTOPOMER DISTRIBUTION ANALYSIS TECHNIQUE WITH TESTING OF ASSUMPTIONS AND POTENTIAL PROBLEMS (*) , 1995, The Journal of Biological Chemistry.

[35]  R Hoh,et al.  Factors influencing T-cell turnover in HIV-1-seropositive patients. , 2000, The Journal of clinical investigation.

[36]  L. Sidossis,et al.  Glucose and insulin-induced inhibition of fatty acid oxidation: the glucose-fatty acid cycle reversed. , 1996, The American journal of physiology.

[37]  F. Bosch,et al.  Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Kyung-sup Kim,et al.  Obese Gene Expression Alters the Ability of 30A5 Preadipocytes to Respond to Lipogenic Hormones* , 1996, The Journal of Biological Chemistry.

[39]  S. Young,et al.  Metabolic adaptations to dietary fat malabsorption in chylomicron-deficient mice. , 1999, The Biochemical journal.

[40]  M. Hellerstein,et al.  De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption. , 1999, The American journal of clinical nutrition.

[41]  Robert V Farese,et al.  A genetic model for absent chylomicron formation: mice producing apolipoprotein B in the liver, but not in the intestine. , 1995, The Journal of clinical investigation.

[42]  M. Hellerstein,et al.  Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: studies in vitro, in animals, and in humans. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  N Symonds What is Life?: Schrodinger's Influence on Biology , 1986, The Quarterly Review of Biology.

[44]  J. Volpe,et al.  Mechanisms and regulation of biosynthesis of saturated fatty acids. , 1976, Physiological reviews.

[45]  M. Hellerstein,et al.  Effect of dietary energy restriction on glucose production and substrate utilization in type 2 diabetes. , 2000, Diabetes.

[46]  J. Flatt Dietary fat, carbohydrate balance, and weight maintenance: effects of exercise. , 1987, The American journal of clinical nutrition.

[47]  S. Klein,et al.  Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity. , 2003, American journal of physiology. Endocrinology and metabolism.

[48]  N. Schork,et al.  Genetic Analysis of NIDDM: The Study of Quantitative Traits , 1996, Diabetes.

[49]  G. Stephanopoulos,et al.  Network rigidity and metabolic engineering in metabolite overproduction , 1991, Science.

[50]  V. McKusick Mendelian inheritance in man , 1971 .

[51]  A. Attie,et al.  Please pass the chips: genomic insights into obesity and diabetes. , 2001, The Journal of nutrition.